Serous cystadenocarcinoma
| Serous cystadenocarcinoma | |
|---|---|
 | |
| Ovarian cancers in women aged 20+, with area representing relative incidence and color representing 5-year relative survival rate.[1] Serous cystadenocarcinoma is labeled at bottom left. | |
 | |
| Pronunciation | |
Serous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping.
Most commonly, the primary site of serous cystadenocarcinoma is the ovary. Rare occurrence in the pancreas has been reported, although this is not typical, with the majority of microcystic pancreatic masses representing alternate disease processes such as the more benign serous cystadenoma.[1][2][3]
Serous cystadenocarcinoma
References
- 1 2 Kosary CL (2007). "Chapter 16: Cancers of the Ovary". In Ries LA, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ (eds.). SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. SEER Program. Bethesda, MD: National Cancer Institute. pp. 133–144. Archived from the original on 2013-10-10.
- ↑ King JC, Ng TT, White SC, Cortina G, Reber HA, Hines OJ (October 2009). "Pancreatic serous cystadenocarcinoma: a case report and review of the literature". Journal of Gastrointestinal Surgery. 13 (10): 1864–1868. doi:10.1007/s11605-009-0926-3. PMC 2759006. PMID 19459016.
- ↑ Friebe V, Keck T, Mattern D, Schmitt-Graeff A, Werner M, Mikami Y, et al. (August 2005). "Serous cystadenocarcinoma of the pancreas: management of a rare entity". Pancreas. 31 (2): 182–187. doi:10.1097/01.mpa.0000167001.89018.3c. PMID 16025006.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.